Sign inJoin Free
DashboardSign out
Free Lesson Preview
Module 1: Lesson 1
Medical care and safety reporting
Master the investigator's dual obligation to provide qualified medical care during trial participation and to report adverse events accurately according to protocol-specified timelines.
Medical care and safety reporting
When a participant enrolls in a clinical trial, something profound happens. They place their health, at least in part, in the hands of the investigator. They trust that if something goes wrong, someone qualified will recognize it and respond appropriately. They trust that their experience will inform decisions about whether others should face similar risks.
This trust is not misplaced, but it is not automatic either. It must be earned through the investigator's vigilance, competence, and commitment to both treating adverse events and reporting them. These are the twin pillars of Section 2.7: medical care and safety reporting.
I have spent decades observing how sites handle adverse events, and I can tell you that the difference between excellent and mediocre safety management often comes down to something simple. Does the site treat adverse events as inconvenient interruptions to be documented and forgotten, or as clinical obligations that demand genuine medical attention and meticulous reporting? The former approach technically complies with requirements. The latter actually protects participants.
Section 2.7 of ICH E6(R3) Annex 1 codifies what excellent sites already know: participants deserve both competent medical care when adverse events occur and confidence that their experience will be captured accurately enough to protect future participants.
What you will learn
By the end of this lesson, you will be able to:
Good Clinical Practice (GCP)
Full course · ICH E6(R3) Principles